Earnings
Decibel Reports First Quarter 2026 Results: Quarterly Revenue Grows 41% YoY to $30 Million, Issues Q2 2026 Guidance
Decibel Cannabis Confirms Turnaround Trajectory with Q1 Revenue Surge, Yet FCF Drag Lingers

Executive Summary
- Decibel reported First Quarter 2026 net revenue of $30 million, a 41% year-over-year increase.
- International sales surged 330% YoY to $9.6 million, while domestic sales grew 7% to $20.3 million.
- Adjusted EBITDA doubled YoY to $6.9 million; adjusted net income turned profitable at $3.1 million versus a loss in Q1 2025.
- Free Cash Flow was negative ($14.6 million) due primarily to a one-time $13.2 million reduction in payables settled via debt refinancing.
- Company issued Q2 2026 revenue guidance of $33 million to $35 million and reaffirmed full-year 2026 guidance ($130M-$135M Revenue, $27M-$31M EBITDA).
- Germany shipments completed in Q1; management expects growth as permit processing improves.
- Creston property sale agreement remains conditional with expected completion before June 30, 2026, saving $4 million annually.
Material Impact
- The earnings results confirm the trajectory established in the April 2026 full-year guidance release; revenue and EBITDA growth are consistent with expectations rather than surprising upside.
- International sales tripling (330%) validates the AgMedica integration strategy but does not constitute a new strategic shift, as this was anticipated following the February debt refinancing.
- The reaffirmation of full-year guidance after previous cuts in November 2025 reduces execution risk but is largely priced into the stock given the April announcement.
- Free Cash Flow negative reading is explained by a non-recurring working capital adjustment ($13.2M payable settlement), masking underlying operational cash generation which was positive in prior quarters (e.g., Q4 2025 FCF $3 million).
- The debt refinancing closed in February extends maturities to 2030, removing near-term solvency risk but increasing leverage on the balance sheet.
- Overall impact is positive for operational stability but lacks the "unexpected" element required for a Material - Game Changer or Material - Positive rating under strict definitions.
DB · Price
Company Overview
- Decibel Cannabis Company Inc. operates as a vertically integrated cannabis producer with a focus on ready-to-consume products and international export.
- Flagship Project: AgMedica Bioscience integration for international GMP-extracted product supply, specifically targeting Germany and other regulated markets.
- Domestic Portfolio: Brands include General Admission (Liquid Diamond 510) and Standard Issue (Vape/Pre-Roll).
- Processing Capacity: 60 tons per annum flower processing capacity at ~30% utilization; consolidation planned with Battleford facility.
- Market Position: Canadian recreational market share grew from 4.1% to 4.4%; International sales now represent significant growth driver (330% YoY).
More from Decibel Cannabis Company Inc.
Apr 16, 2026 · 08:00